Download this datacard
Overview
Lobbying Costs
1,250,000€ - 1,499,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
3.25 Fte (6)
Lobbyists with EP accreditation
6
High-level Commission meetings
16
Lobbying Costs over the years
-
Info
Merck
EU Transparency Register
49654992078-52 First registered on 28 Jul 2009
Goals / Remit
Merck, a leading science and technology company, generated total revenues of €22,2 billion in 2022 with its divisions Healthcare, Electronics and Life Science. More than 64,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent stakes, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are the United States and Canada. Here Merck operates as EMD Serono in the Biopharma business, MilliporeSigma in the Life Science business, and as EMD Performance Materials in the Performance Materials/Electronics business.
Main EU files targeted
Clean Industrial Deal, EU Economic Security Strategy, EU Competitiveness and all relevant policies/initiatives such as:
Chemicals Strategy for Sustainability - REACH revision, Industrial Emissions Directive, Clean Air and Water, Fit-for-55, CLP regulation, Circular Economy policies, PFAS, CBAM
Raw-Materials Act
Digital Policies (i.e. EU Chips-Act, EU AI Act, EHDS)
Trade policies (eg Global Gateway, customs regulations, TTC developments)
Sustainable Finance (eg Taxonomy)
Pharmaceutical Strategy and Health Care related policies.
Intellectual Property (IP) Package
Life Science related policies such as Medicinal Products Directive.
Sanctions Packages on Russia etc.Address
Head Office
Frankfurter Strasse 250
Darmstadt 64293
GERMANYEU Office
Rue Belliard 40
Brüssel 1040
BELGIUMWebsite
-
People
Total lobbyists declared
6
Employment time Lobbyists 75% 3 50% 1 25% 2 Lobbyists (Full time equivalent)
3.25
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
6 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Sabrina CONTI 22 Oct 2024 21 Oct 2025 Franjo CAIC 16 Oct 2024 15 Oct 2025 ANA M POLANCO ALVAREZ 16 Oct 2024 15 Oct 2025 Elisa Díaz Martínez 22 Oct 2024 21 Oct 2025 Jean-Paul El Ahl 14 Sep 2024 13 Sep 2025 Liesbet DENDAS 25 Jun 2024 24 Jun 2025 Elisa DIAZ MARTINEZ 06 Dec 2023 04 Oct 2024 Sabrina CONTI 24 Jan 2024 04 Oct 2024 Maike BECKER-KRÜGER 10 May 2023 10 May 2024 Ana POLANCO ALVAREZ 24 Jan 2024 04 Oct 2024 Jean Paul Andre EL AHL 14 Sep 2023 14 Sep 2024 Franjo CAIC 14 Oct 2023 04 Oct 2024 Ana POLANCO ALVAREZ 01 Mar 2023 24 Jan 2024 Sabrina CONTI 19 Jan 2023 18 Jan 2024 Mr Tim MERTENS 14 Dec 2022 10 May 2023 Franjo CAIC 29 Oct 2022 14 Oct 2023 Ms Liesbet DENDAS 06 Jul 2022 06 Jul 2023 Jean Paul Andre EL AHL 06 Jul 2022 06 Jul 2023 Mr Tim MERTENS 09 Oct 2021 08 Oct 2022 Franjo CAIC 08 Oct 2021 08 Oct 2022 Jean Paul Andre EL AHL 25 Aug 2021 06 Jul 2022 Ms Anne PAPIN DI POMPEO 27 Jul 2021 27 Jul 2022 Mr Hugh Thomas PULLEN 20 Feb 2020 20 Feb 2021 Ms Anne PAPIN DI POMPEO 20 Feb 2020 20 Feb 2021 Ms Mihaela Militaru 20 Feb 2020 20 Feb 2021 Ms Irene Maria DE CARA 20 Feb 2020 20 Feb 2021 Ms Vanessa POTT 20 Feb 2020 20 Feb 2021 Mr Tim MERTENS 19 Nov 2019 01 Dec 2020 Ms Isabel VLACHOPOULOU KLINNERT 27 Mar 2019 27 Mar 2020 Ms Anne PAPIN DI POMPEO 16 Jan 2019 16 Jan 2020 Ms Mihaela Militaru 16 Jan 2019 16 Jan 2020 Mr Hugh Thomas PULLEN 08 Jan 2019 01 Jan 2020 Ms Irene Maria DE CARA 08 Jan 2019 01 Jan 2020 Ms Vanessa POTT 04 Oct 2018 01 Nov 2019 Franjo CAIC 28 Mar 2018 28 Mar 2019 Ms Isabel VLACHOPOULOU KLINNERT 15 Mar 2018 15 Mar 2019 Mr Hugh Thomas PULLEN 25 Nov 2017 24 Nov 2018 Ms Mihaela Militaru 25 Nov 2017 24 Nov 2018 Ms Irene Maria DE CARA 25 Nov 2017 24 Nov 2018 Ms Anne PAPIN DI POMPEO 31 Aug 2017 31 Aug 2018 Ms Vanessa POTT 20 Jul 2017 20 Jul 2018 Ms Sara-Andrada Dumitrana 22 Mar 2017 21 Mar 2018 Franjo CAIC 22 Mar 2017 21 Mar 2018 Mr Hugh Thomas PULLEN 09 Nov 2016 09 Nov 2017 Ms Irene Maria DE CARA 04 Nov 2016 03 Nov 2017 Ms Mihaela Militaru 28 Oct 2016 28 Oct 2017 Mr Marcel Daniels 19 Jul 2016 08 Jul 2017 Ms Sara-Andrada Dumitrana 16 Feb 2016 04 Feb 2017 Mr Marcel Daniels 17 Jun 2015 15 Jun 2016 Mr Hugh Thomas PULLEN 17 Jun 2015 15 Jun 2016 Ms Sara-Andrada Dumitrana 04 Nov 2014 30 Oct 2015 Mrs Sara-Andrada Dumitrana 04 Nov 2014 27 Jan 2015 Mr Hugh Thomas PULLEN 07 Jun 2014 05 Jun 2015 Mr Marcel Daniels 06 May 2014 15 Apr 2015 Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Merck is a member of CEFIC (EU), EFPIA (EU), EBE - European Biopharmaceutical Enterprises (EU), EuropaBio, BVAC (DE with EU-office), VCI (DE) and its sub-state organisations such as LV Hessen, and DIB (Deutsche Industrievereinigung Biotechnologie), Bundesverband der deutschen Industrie (BDI), Verband forschender Arzneimittelhersteller (DE), World Economic Forum (WEF), Bitkom (DE), European Round Table forIndustry (ERT), Cosmetics Europe, EUCCC (European Chamber of Commerce), ACATECH and various other sectoral organisations mainly at respective national/regional levels in the countries such as European General Counsel Association (UK), European Process Safety Center (UK), European Centre for Ecotoxicology and Toxicology of Chemicals (BE)
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
1,250,000€ - 1,499,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount harwood levitt consulting 100,000€ - 199,999€ nove 50,000€ - 99,999€ Intermediaries for current year
Name harwood levitt consulting nove Closed year Costs
1,250,000€ - 1,499,999€
Other financial info
Costs increased in 2023 due to the high number of important files that required more work with EU Institutions (General Pharmaceutical Legislation, Green Deal, PFAS, Chips and AI,...).
-
EU Structures
Groups (European Commission)
Expert Group Global Gateway Business Advisory Group#E03898#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3898 #MEMBER #C#IndustryGG BAG sub-group on Health Sector#E03898/3#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=104596 #MEMBER #C#Industry
Groups (European Parliament)
N/A
Communication activities
2023: Sponsoring of a Health Talk in Brussels on the topic of the General Pharmaceutical Strategy, with representatives of EU parliament and other stakeholders.
Other activities
None declared
Meetings
Meetings
16 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 05 Jun 2023 Location Brussels Subject Trade & Technology Council, Global Steel and Aluminum Arrangement, Critical Minerals Agreement Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Zaneta Vegnere (Cabinet member)
- Elina Melngaile (Cabinet member)
Other Lobbyists -
Date 18 Feb 2023 Location München Subject Review of pharmaceutical legislation. TRIPS waiver. Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Valdis Dombrovskis (Executive Vice-President)
-
Date 18 Jan 2023 Location Davos, Switzerland Subject Deep tech innovation for life sciences & biological components EU Innovation Agenda EU Mission on cancer R&I for health EU Research on semi-conductors Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Digital Economy and Society Attending - Mariya Gabriel (Commissioner)
-
Date 18 Jan 2023 Location Davos, Switzerland Subject Deep tech innovation for life sciences & biological components EU Innovation Agenda EU Mission on cancer R&I for health EU Research on semi-conductors Cabinet Cabinet of Commissioner Mariya Gabriel Portfolio Innovation and Youth Attending - Mariya Gabriel (Commissioner)
-
Date 08 Nov 2022 Location Brussels Subject Share initiatives and explore ways of collaboration and synergy Cabinet Cabinet of Commissioner Helena Dalli Portfolio Equality Attending - Lesia Radelicki (Cabinet member)
-
Date 07 Sep 2022 Location Webex Subject Revision of the pharmaceutical legislation. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Karolina Herbout-Borczak (Cabinet member)
-
Date 04 Apr 2022 Location virtual Subject Current issues such as the transformation of the European economy, and how the Chemical and Pharmaceutical industry Cabinet Cabinet of Commissioner Paolo Gentiloni Portfolio Economy Attending - Alienor Margerit (Cabinet member)
-
Date 30 Nov 2021 Location Brussels Subject Pharma Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 26 Oct 2021 Location Brussels Subject Pharmaceutical sector – trade related issues Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Elina Melngaile (Cabinet member)
- Kevin Keary (Cabinet member)
- Caroline Boeshertz (Cabinet member)
Other Lobbyists -
Date 03 Sep 2021 Location Brussels Subject FF55 and the pharmaceutical industry DG Climate Action Attending - Mauro Raffaele Petriccione (Director-General)
-
Date 12 Apr 2021 Location Brussels Subject Global supply chains for disposables Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 02 Mar 2021 Location videoconference Subject Vaccine production Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 29 May 2018 Location Brussels Subject Preparation of the IMI 10th Anniversary Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 14 Nov 2017 Location Strasbourg Subject Circular economy, priorities of Juncker Commission and AMR (Antimicrobial Resistance) Action Plan DG Communication Attending - Timo Pesonen (Director-General)
-
Date 23 Nov 2016 Location Brussels Subject EPFIA's Priorities Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Giulia Del Brenna (Cabinet member)
-
Date 22 Apr 2016 Location Brussels Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Annika Nowak (Cabinet member)